InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.81%
)
Bitcoin
68,878.76
(
1.40%
)

Replies to post #7869 on Provectus Biopharmaceuticals Inc (PVCT)

Replies to #7869 on Provectus Biopharmaceuticals Inc (PVCT)

Paulness

09/23/15 2:17 PM

#7870 RE: Paulness #7869

The cost of pembrolizumab is reimbursed so it is not paid for by Provectus and the remaining cost of this study is budgeted with existing cash on hand of the Company.